Drug
NO Investigational Product
NO Investigational Product: highest development phase Phase 3, developed by Ultragenyx Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| No Investigational Product NCT04360265 | Phase 3 | Mucopolysaccharidosis IIIA |
Latest
No recent events.
Follow NO Investigational Product on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.